WebObjective: This study aimed to elucidate the residual disease distribution and recurrence patterns in patients with ESCC responding to NAC. Summary background data: To appropriately plan a prospective trial for the organ preservation approach which includes additional chemoradiotherapy in patients who responded to NAC, the distribution of … Web104 Background: JCOG0909, a single-arm confirmatory trial of definitive chemoradiotherapy (dCRT) including salvage treatment, demonstrated promising efficacy and safety for cStage II/III ...
お勉強39:JCOG0909試験最終結果|nijuoti|note
Web1 feb 2024 · Definitive CRT was as an option for patients who refuse surgery or is unsuitable for surgery because of complications from the result of JCOG0909 study (3,4,15). ... WebUMIN Clinical Trials Registry. Unique ID issued by UMIN. UMIN000003534. Receipt number. R000004179. Scientific Title. A non-randomized confirmatory study of definitive chemoradiotherapy including salvage treatment in patients with clinical stage II/III esophageal carcinoma (JCOG 0909,EC-CRT+Salvage-sP3) Date of disclosure of the … hurts to lift arm above head
A Single-Arm Confirmatory Study of Definitive ... - ScienceDirect
WebcStage II/III,5 and 15%-33% in cT4 ESCC.6,7 In the recent JCOG0909 trial, the cCR rate was 59% in cStage II/III ESCC.8 Despite this high cCR rate, recurrence was reported in 40%-60% of cases.4,6 Relapse patterns of the ESCC varied among patients with stage II/III (exclud-ing T4) who achieved cCR to dCRT.9 Web28 apr 2024 · Background JCOG0909 is a phase II trial of definitive chemoradiotherapy including salvage treatment for cStage II–III thoracic esophageal cancer; the radiation … Web10 dic 2024 · In fact, the JCOG0909 trial showed a favourable 3-year overall survival of 74% for Stage II/III ESCC. Although the result needs to be carefully interpreted as it was a single-arm, phase II trial, the definitive CRT followed by salvage oesophagectomy as needed can be potentially equivalent to NAC followed by surgery . maryland dmv registration cost